Spina bifida is a birth defect that occurs when the spinal cord and backbone do not form properly during early pregnancy. Spina bifida in-utero repair is performed during pregnancy to repair spina bifida defects of an unborn baby before birth. The procedure involves using minimally invasive surgery techniques through small incisions in the mother's abdomen and uterus. This helps reduce the risks associated with standard postnatal surgery and provides better outcomes for the baby such as reduced need for shunts.
The Spina Bifida In-Utero - Market is estimated to be valued at USD 2.71 billion in 2024 and is expected to reach USD 4.89 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031.
Key players operating in the spina bifida in-utero repair market are Johns Hopkins Medicine, Cincinnati Children's Hospital, and Vanderbilt University Medical Center.
Key Takeaways
Key players: Johns Hopkins Medicine, Cincinnati Children's Hospital, and Vanderbilt University Medical Center are considered pioneers in spina bifida in-utero repair procedures globally. They have vast expertise and experience in performing these complex fetal surgeries.
Growing demand: Rising incidence of neural tube defects during pregnancy is a major factor fueling demand for Spina bifida In-Utero Market repair procedures. According to the Centers for Disease Control and Prevention, spina bifida affects nearly 1,500 babies in the United States each year.
Technological advancements: Introduction of advanced imaging modalities such as 3D ultrasound and fetal MRI is enabling physicians to better detect and monitor spina bifida conditions during pregnancy. Novel minimally invasive surgical techniques are also being developed to repair defects in an utero safely.
Market Trends
multi-institutional clinical trials: Large multi-institutional clinical trials are being conducted to further validate the long-term benefits of spina bifida in-utero repair compared to postnatal surgery. The Management of Myelomeningocele Study (MOMS) trial significantly changed the clinical practice guidelines.
Increased accessibility: With rising success rates, more healthcare facilities across countries are establishing fetal surgery programs to make spina bifida in-utero repair services accessible to more patients. This will help address unmet needs in underpenetrated regions.
Market Opportunities
Developing regions: There is high unmet demand for fetal surgery in developing Asian, Latin American and Middle Eastern countries where spina bifida prevalence is significant. Partnerships with local healthcare providers can help established Leaders expand Their geographic Footprint.
New technologies: Areas such as fetoscopic instruments, advanced suturing devices and imaging systems present considerable opportunities for new product development. Innovations aimed at reducing invasiveness, costs and improving outcomes will drive future adoption.
Impact of COVID-19 on Spina Bifida In-Utero Market growth
The COVID-19 pandemic has impacted the growth of the Spina Bifida In-Utero market. During the peak of the pandemic, most non-emergency surgeries and procedures were postponed to reduce the burden on healthcare resources and infrastructure. This led to a decline in the number of procedures carried out for prenatal diagnosis and fetal surgeries to repair neural tube defects like Spina Bifida. However, with healthcare systems adapting to the 'new normal' and resuming non-COVID care, the market is witnessing a gradual recovery. Factors like the enhanced safety protocols, increased teleconsultations for high-risk patients, and advancements in minimally invasive fetal surgery techniques will support market growth in the post-pandemic period. Manufacturers are also developing advanced ultrasound imaging solutions to aid remote prenatal diagnosis. Overall, while short-term disruptions were unavoidable, initiatives to optimize care pathways suggest the long-term prospects for this market remain positive.
Geographical concentration of Spina Bifida In-Utero Market
In terms of value, the Spina Bifida In-Utero market is highly concentrated in North America and Western Europe. This is due to the high adoption of advanced prenatal screening and diagnostic technologies in these regions. Countries like the United States and Germany have a large number of fetal treatment centers that regularly perform open and minimally invasive fetal surgeries to repair Spina Bifida defects. Supported by favorable reimbursement policies and rising healthcare expenditures, these regions account for over 60% of the global market value. However, with growing medical tourism and the establishment of new specialty clinics, other regions like Asia Pacific and Latin America are anticipated to increase their market share over the coming years.
Increasing demand in developing economies
The Spina Bifida In-Utero market is witnessing the fastest growth in developing countries of Asia Pacific and Latin America. Thanks to improving economic conditions and expanding medical infrastructure, countries like India, Brazil, China are emerging as important markets. Rising health awareness, growing middle-class populations who can afford sophisticated care, and government initiatives to strengthen neonatal health programs are driving the demand. Additionally, these regions have a high incidence of neural tube defects due to factors like poor nutrition. This is leading to an increase in prenatal diagnosis volumes and a need for advanced fetal therapies. Overall, with continued investments to develop world-class pediatric healthcare, Asia Pacific will be critical in fueling the future expansion of this market.
Get more insights on : Spina bifida In-Utero Market
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
